Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Practical Tips for Patients Living with a new medication can sometimes feel overwhelming, especially when you notice changes in your body that you are not used to
Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines
Out of stock now
AbbVie / Pharmacyclics ($21B, 2015): Valuing the Patent Wall At $21 billion, AbbVie acquired an asset, ibrutinib (Imbruvica), that had generated approximately $1 billion in revenue in its first full year of commercial sale
US$ 27.97
US$ 26.74
US$ 24.28
US$ 22.94
US$ 21.18
US$ 24.14
US$ 20.22
US$ 20.22
US$ 25.82
US$ 24.65
US$ 24.87
US$ 28.28
US$ 23.80
US$ 28.04
